Nasus Pharma（NSRX.US）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

© 2026 Longbridge｜服务条款隐私政策

股东类型

个人与内部人士34.25%
公众及其他33.20%
机构投资者13.41%
私营企业11.47%
对冲基金7.67%

主要股东

主要股东最新
股东
Ehud GilboaCo-Founder & Executive Chairman	16.39%	191.93 万	0.00%	+0	2026/03/18
Dalia MegiddoCo-Founder, Director, Chief Medical Officer & Chief Development Officer?	16.13%	188.89 万	0.00%	+0	2026/03/18
Hershman Holdings LLC	7.76%	90.92 万	0.00%	+0	2026/08/17
Balyasny Asset Management L.P.	7.67%	89.85 万	0.00%	+0	2026/08/17
Capital Point Ltd.	4.91%	57.51 万	0.00%	+0	2025/08/14
Phoenix Solutions Ltd	3.67%	42.93 万	0.00%	+0	2026/03/18
Cable Car Capital LLC	3.07%	35.94 万	2.19%	-25.67 万	2026/08/17
Velan Capital Partners LP	3.07%	35.94 万	0.00%	+0	2026/08/17
Galia KryazDirector of CMC & Product Development	1.47%	17.17 万	0.00%	+0	2025/08/13
Hudson Bay Capital Management LP	1.15%	13.48 万	0.00%	+0	2026/06/30
Bleichroeder LP	0.77%	8.98 万	0.00%	+0	2026/06/30
Dan TelemanFormer CEO & Director	0.26%	3.07 万	0.08%	+9,450.00	2026/06/17
Citadel Advisors LLC	0.19%	2.20 万	--	+2.20 万	2026/06/30
XTX Markets Limited	0.14%	1.66 万	--	+1.66 万	2026/06/30
Renaissance Technologies LLC	0.10%	1.22 万	--	+1.22 万	2026/06/30
Formulex Pharma Innovations Ltd	0.04%	5,195.00	0.00%	+0	2026/03/18
Morgan Stanley	<0.01%	1,000.00	<0.01%	-1,000.00	2026/06/30
Tair Lapidot	<0.01%	10.00	0.00%	+0	2025/08/13
Caitong International Asset Management Co., Limited	<0.01%	4.00	--	+4.00	2026/06/30
Oren ElmaliachFormer Director of Finance	0.00%	0.00	0.00%	+0	2025/08/13